Fig. 2From: Prognostic mutational subtyping in de novo diffuse large B-cell lymphomaDichotomized risk model of NMF groups and adjusted multivariate model. PFS of merged groups with similar prognostic profiles into a high-risk group (purple, CD79B/MYD88 and BCL2/EZH2), and low-risk group (green, NOTCH2/TNAIFP3 and ‘no mutations’). NMF, non-negative matrix factorization; PFS, progression-free survivalBack to article page